Alibaba Bump: 89% of Funds That Own It Are Beating Benchmark
(Bloomberg) -- U.S. mutual funds struggling to get ahead of passive indexes this year had a solution handed to them on a platter: Alibaba Group Holdings Ltd.
Among 215 large-cap growth funds in the U.S., about one-third hold shares of the New York-listed Chinese e-commerce giant, according to regulatory filings compiled by Bloomberg. They've returned an average 33 percent this year, compared with 24 percent from managers with no stake.
Among funds with BABA on board, 89 percent are beating their benchmarks in 2017, versus 52 percent without it.
The gap exists because Alibaba has surged 113 percent and isn't in any of the biggest American equity indexes. The increase of $260 billion in market value would've been like adding a second Apple Inc. were Alibaba in the S&P 500. But since it isn't, owning it has been gravy for mutual funds measured against it.
“Alibaba has been the shining star,” said Todd Rosenbluth, director of ETFs and mutual funds research at CFRA in New York. “Owning something that's off the benchmark and doubled is going to be a significant tailwind for performance.”
The spread in returns highlights a rare instance when listing standards observed by the biggest index providers act almost like stock picking mistakes for investors in passive funds. S&P Dow Jones Indices ruled in September 2014 that Alibaba was ineligible for the best known U.S. equity gauges due to its China domicile. The stock is also excluded from benchmarks such as the Russell 1000 Index.
Alibaba's performance is reminiscent of what Apple did in 2014. That year, failing to own the iPhone maker was one reason why funds trailed benchmark indexes by the most in almost a decade.
What's unusual this time is that the appreciation is in a non-American company. Investors have to go back to 2007 to find a similar instance when a U.S.-listed foreign stock added more in market value than Alibaba has done this year while not being included in major benchmarks. Back then it was another China behemoth, PetroChina Co.
“A lot of funds may have strict mandate” that doesn't allow them to invest in Alibaba, said Katie Reichart, associate director of manager research at Morningstar Inc. in Chicago. Still, some of them “have gone against the grain, ridden out of benchmark picks and it's been working out for them.”
Hedge funds that have more flexibility picking stocks didn't shy away from scooping up Alibaba shares though. The stock is among the top five in Goldman Sachs Group Inc.'s hedge fund VIP basket of the industry's most favored companies.
Alibaba shares slipped 0.7 percent yesterday, trimming the November gain to 1 percent.
To contact the reporter on this story: Lu Wang in New York at lwang8@bloomberg.net.
To contact the editors responsible for this story: Arie Shapira at ashapira3@bloomberg.net, Chris Nagi, Eric J. Weiner
©2017 Bloomberg L.P.
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
-
Wrong Labels, High Pesticide Residues Holding Back Agri Exports | The Reason Why
India needs stronger domestic food-safety and labelling standards, with best practices becoming part of everyday business for farmers, traders and food companies.